Columns

I miss someone. I don’t even know her … and yet I miss her. I miss the person I do not see on TV, in the movies, or portrayed in most media to date. She needs to be here. And I want to write her. The person I’m referencing is…

Loureen and I waited for our travel buddies to pass through airport security. Soon, we would be on a plane to Jordan, where we would provide various forms of support to Syrian refugees escaping civil war. Loureen, wise and a smidge or two older than me, looked me up and…

Today I had a meltdown. I don’t like to think of myself as someone who has “meltdowns,” but lately they are happening more and more. It started logically; I was feeling the familiar pains of pseudo-pancreatitis — the pale-poop, swollen-belly, mystery nuisance — which usually means I can’t eat.

Six months ago, if I had been tied to a very uncomfortable chair and tortured for weeks while interrogators screamed, “What is your greatest fear?” the only things I could have come up with would have been maybe … centipedes. Or dying in a hospital bed. Or maybe that the…

Two weeks ago, I watched a livestream of the North American Cystic Fibrosis Conference (NACFC) as I popped Trikafta (elexacaftor/tezacaftor/ivacaftor) tablets out of their blister pack. Francis Collins, one of the researchers who discovered the cystic fibrosis transmembrane conductance regulator (CFTR) gene, was singing to an audience of…

I don’t write much about my work at BioNews Services, which publishes Cystic Fibrosis News Today. I guess doing so seems a bit awkward since I’m a senior director at the company. In my gig, I head the columns division, which publishes patient and caregiver voices across dozens of rare…

I’m writing this column on the day I start treatment with Trikafta (elexacaftor/tezacaftor/ivacaftor), a new cystic fibrosis (CF) medication that I believe will be regarded as an inflection point in CF history. If you’re involved in the CF community or have been on social media in recent weeks,…

At this time last week, I was crying. I was crying because I didn’t “want to let them down.” The potentially disappointed party in question was a new company within my professional dance company, aptly titled “Comebacks.” Initially, I wanted Comebacks to be the ultimate “comeback” for former…

It’s time to move forward. The recent approval by the U.S. Food and Drug Administration of the triple-combination treatment Trikafta (elexacaftor, tezacaftor, and ivacaftor) has sparked hope in the cystic fibrosis community. While it’s not a cure, the therapy has shown to have positive…

Last week, the Cystic Fibrosis Foundation launched a new initiative called “Path to a Cure.” A press release called it “an ambitious research agenda to deliver treatments for the underlying cause of the disease and a cure for every person with cystic fibrosis (CF).” It added: “The Foundation is…